Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.46 - $5.33 $670,617 - $1.03 Million
-193,820 Reduced 79.05%
51,375 $251,000
Q3 2023

Nov 14, 2023

BUY
$5.07 - $8.44 $260,912 - $434,339
51,462 Added 26.56%
245,195 $1.34 Million
Q2 2023

Aug 14, 2023

SELL
$6.19 - $8.78 $884,142 - $1.25 Million
-142,834 Reduced 42.44%
193,733 $1.3 Million
Q1 2023

May 15, 2023

SELL
$7.8 - $10.11 $554,322 - $718,487
-71,067 Reduced 17.43%
336,567 $2.97 Million
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $662,808 - $988,919
105,880 Added 35.09%
407,634 $3.11 Million
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $562,224 - $1.1 Million
86,496 Added 40.18%
301,754 $2.15 Million
Q2 2022

Aug 15, 2022

BUY
$6.4 - $14.73 $837,132 - $1.93 Million
130,802 Added 154.88%
215,258 $1.74 Million
Q1 2022

May 16, 2022

BUY
$10.12 - $28.9 $534,973 - $1.53 Million
52,863 Added 167.33%
84,456 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $616,035 - $901,903
24,475 Added 343.85%
31,593 $886,000
Q3 2021

Nov 15, 2021

SELL
$30.02 - $39.87 $3.03 Million - $4.02 Million
-100,859 Reduced 93.41%
7,118 $242,000
Q2 2021

Aug 16, 2021

SELL
$32.22 - $44.59 $831,823 - $1.15 Million
-25,817 Reduced 19.3%
107,977 $4.41 Million
Q1 2021

May 17, 2021

SELL
$37.26 - $67.74 $3.34 Million - $6.07 Million
-89,545 Reduced 40.09%
133,794 $5.39 Million
Q4 2020

Feb 16, 2021

BUY
$45.01 - $65.47 $5.57 Million - $8.11 Million
123,836 Added 124.45%
223,339 $13.2 Million
Q3 2020

Nov 16, 2020

BUY
$35.79 - $48.81 $2.78 Million - $3.79 Million
77,603 Added 354.35%
99,503 $4.84 Million
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $546,405 - $1.06 Million
21,900 New
21,900 $1.06 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.